AI startup Collate has secured $95 million in a funding round led by Redpoint Ventures, valuing the company at nearly $1 billion. The company utilizes AI to automate administrative tasks within the life sciences sector, such as regulatory filings and clinical trial documentation. Collate reports significant time savings for its clients, ranging from 50% to 90%, and aims to streamline the process of bringing new therapies to market. AI
IMPACT Accelerates automation in life sciences, potentially speeding up drug discovery and regulatory approval.
RANK_REASON Significant funding round for an AI startup in a specific vertical. [lever_c_demoted from significant: ic=1 ai=0.7]
- Boston Scientific
- Conviction Partners
- Harvey
- Lever
- Nate Smith
- NVision Medical
- Redpoint Ventures
- Satish Dharmaraj
- Surbhi Sarna
- Y Combinator
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
